Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort
- 19 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 20 (2), 246-253
- https://doi.org/10.1177/2047487312437713
Abstract
Introduction: For Aboriginal populations, predicting individuals at risk of cardiovascular disease (CVD) is difficult due to limitations and inaccuracy in existing risk-prediction algorithms. We examined conventional and novel risk factors associated with insulin resistance and the metabolic syndrome and assessed their relationships with subsequent CVD events. Design: Longitudinal cohort. Methods: Aboriginal people (n = 739) from Central Australia completed population-based risk-factor surveys in 1995 and were followed up in 2005. Principal components analysis (PCA), regression and univariate analyses (using ROC defined cut-off points) were used to identify useful clinical predictors of primary CVD. Results: PCA yielded five components: (1) lipids and liver function; (2) insulin resistance; (3) blood pressure and kidney function; (4) glucose tolerance; and (5) anti-inflammatory (low fibrinogen, high HDL cholesterol). Components 2, 3 and 4, and age were significant independent predictors of incident CVD, and smoking approached significance. In univariate analysis fasting glucose ≥4.8 mmol/l, total:HDL cholesterol ratio ≥5.7, non-HDL cholesterol ≥4.3 mmol/l, gamma-glutamyl transferase ≥70 U/l, albumin creatinine ratio ≥5.7 mg/mmol, systolic blood pressure ≥120 mmHg and diastolic blood pressure ≥70 mmHg were useful predictors of CVD. The co-occurrence of three or more risk variables (fasting glucose ≥4.8 mmol/l, total:HDL cholesterol ratio ≥5.7, blood pressure (systolic ≥120 mmHg; diastolic ≥70 mmHg; albumin:creatinine ratio ≥5.7 mg/mmol and smoking) had sensitivity of 82.0% and specificity of 59.9% for predicting incident CVD. Conclusion: Age is the strongest predictor of CVD for this population. For clinical identification of individuals at high risk, screening for the combination of three or more of hyperglycaemia, dyslipidaemia, hypertension, albuminuria and smoking may prove a useful and efficient strategy.This publication has 14 references indexed in Scilit:
- Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central AustraliaThe Medical Journal of Australia, 2009
- Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particlesAtherosclerosis, 2008
- Hemostatic factors in Australian Aboriginal and Torres Strait Islander populationsMetabolism, 2007
- Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes MellitusCirculation, 2005
- The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait Islander peoplesDiabetic Medicine, 2005
- Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markersThe Medical Journal of Australia, 2003
- Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and riskDiabetes Research and Clinical Practice, 2002
- Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndromeDiabetologia, 2000
- Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjectsAtherosclerosis, 1998
- Diabetes in Australian Aborigines: impact of the western diet and life styleJournal of Internal Medicine, 1992